ARL4C and cervical carcinoma: It has been shown previously that the level of ARL4C in cultured human cervical carcinoma (HeLa) cells could be increased through the activation of the liver X receptor (LXR) and retinoid X-receptor (RXR) or cholesterol loading [18].